26 related articles for article (PubMed ID: 6259)
21. Catecholamines and pituitary prolactin release.
Ben-Jonathan N
J Reprod Fertil; 1980 Mar; 58(2):501-12. PubMed ID: 6107382
[No Abstract] [Full Text] [Related]
22. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract][Full Text] [Related]
24. Recent findings on prolactin transformation by the lactating rat pituitary.
Mena F; Montiel JL; Aguayo D; Morales MT; Arámburo C
Endocr Regul; 1993 Sep; 27(3):105-13. PubMed ID: 8193309
[No Abstract] [Full Text] [Related]
25. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
Floss HG; Cassady JM; Robbers JE
J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
[No Abstract] [Full Text] [Related]
26. Normal and abnormal prolactin metabolism.
Chang RJ
Clin Obstet Gynecol; 1978 Mar; 21(1):125-37. PubMed ID: 24508
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
